APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data Sources

URL

https://www.globalresearch.ca/wp-content/uploads/2023/05/pfizer-report.pdf

Published Date

June 21, 2022

Organization

Pfizer, Inc.

Description

Tabulation of adverse events categorized by 'system organ class,' including:

Blood and lymphatic system disorders
Cardiac disorders
Endocrine disorders
Gastrointestinal disorders
Immune system disorders
Musculoskeletal and connective tissue disorders
Neoplasms benign, malignant, and unspecified
Nervous system disorders
Pregnancy, puerperium and perinatal conditions
Psychiatric disorders
Reproductive system and breast disorders

Key Excerpts

"Cumulative Reporting Period: Through 18-JUN-2022

Interval Reporting Period: 19-DEC-2021 Through 18-JUN-2022

Total Number of Cases: 507,683 (Interval) / 1,485,027 (Cumulative)

Total Number of Adverse Events (PT): 1,591,026 (Interval) / 4,964,106 (Cumulative)"

"We encourage our readers to cross-post and/or forward Global Research articles, post them on social media, submit them to internet discussion groups, send them to your friends on your e-mail lists, etc. This will help Global Research in its endeavors."

Source: https://www.globalresearch.ca/about-2

Medium

document

Topics

adverse events,adverse-event reporting systems,COVID-19,vaccines